Reliant Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $763K | Sell |
979
-22
| -2% | -$17.2K | 0.33% | 36 |
|
2025
Q1 | $827K | Sell |
1,001
-10
| -1% | -$8.26K | 0.43% | 33 |
|
2024
Q4 | $780K | Sell |
1,011
-376
| -27% | -$290K | 0.34% | 38 |
|
2024
Q3 | $1.23M | Buy |
1,387
+59
| +4% | +$52.3K | 0.58% | 35 |
|
2024
Q2 | $1.2M | Sell |
1,328
-10
| -0.7% | -$9.05K | 0.57% | 37 |
|
2024
Q1 | $1.04M | Hold |
1,338
| – | – | 0.49% | 37 |
|
2023
Q4 | $780K | Sell |
1,338
-44
| -3% | -$25.6K | 0.4% | 39 |
|
2023
Q3 | $742K | Sell |
1,382
-50
| -3% | -$26.9K | 0.43% | 37 |
|
2023
Q2 | $672K | Hold |
1,432
| – | – | 0.39% | 39 |
|
2023
Q1 | $492K | Sell |
1,432
-70
| -5% | -$24K | 0.31% | 39 |
|
2022
Q4 | $549K | Sell |
1,502
-130
| -8% | -$47.6K | 0.33% | 36 |
|
2022
Q3 | $528K | Buy |
1,632
+315
| +24% | +$102K | 0.38% | 33 |
|
2022
Q2 | $427K | Hold |
1,317
| – | – | 0.3% | 34 |
|
2022
Q1 | $377K | Hold |
1,317
| – | – | 0.19% | 41 |
|
2021
Q4 | $364K | Sell |
1,317
-165
| -11% | -$45.6K | 0.15% | 50 |
|
2021
Q3 | $342K | Hold |
1,482
| – | – | 0.17% | 49 |
|
2021
Q2 | $340K | Hold |
1,482
| – | – | 0.16% | 54 |
|
2021
Q1 | $277K | Hold |
1,482
| – | – | 0.14% | 50 |
|
2020
Q4 | $250K | Buy |
1,482
+59
| +4% | +$9.95K | 0.13% | 50 |
|
2020
Q3 | $211K | Buy |
1,423
+165
| +13% | +$24.5K | 0.14% | 57 |
|
2020
Q2 | $207K | Buy |
+1,258
| New | +$207K | 0.15% | 40 |
|
2018
Q2 | – | Sell |
-34,979
| Closed | -$2.71M | – | 52 |
|
2018
Q1 | $2.71M | Buy |
34,979
+505
| +1% | +$39.1K | 2.01% | 32 |
|
2017
Q4 | $2.91M | Buy |
+34,474
| New | +$2.91M | 1.99% | 32 |
|